Quality status of Bombyx Batryticatus and suggestions for Chinese Pharmacopoeia (2025).
10.19540/j.cnki.cjcmm.20230413.102
- Author:
Yong-Hong YANG
1
;
Mei WANG
1
;
Ye-Min CHONG
1
;
Hong-Mei DENG
1
;
Meng-Lian JIANG
1
;
Zhuan-Zhen YANG
1
;
Yu-Hao YAN
1
;
Jing-Liang QI
2
;
Min LI
1
;
Yan GOU
2
Author Information
1. State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy/School of Modern Chinese Medicine Industry, Chengdu University of Traditional Chinese Medicine Chengdu 611137, China.
2. National Medical Products Administration Key Laboratory for Quality Evaluation of Traditional Chinese Medicine (Traditional Chinese Patent Medicine), Sichuan Institute for Drug Control (Sichuan Testing Center of Medical Devices) Chengdu 611731, China.
- Publication Type:Journal Article
- Keywords:
Bombyx Batryticatus;
beauvericin;
infection age;
quality status;
silk gland;
total ash
- MeSH:
Animals;
Bombyx;
Medicine, East Asian Traditional;
Silk;
Larva
- From:
China Journal of Chinese Materia Medica
2023;48(15):4087-4096
- CountryChina
- Language:Chinese
-
Abstract:
To understand the current quality status and rearing situation of Bombyx Batryticatus, the authors collected 102 batches of Bombyx Batryticatus from different main producing areas and five major Chinese medicine markets from 2016 to 2018, and measured the properties and quality of the silk gland, to clarify the quality status of Bombyx Batryticatus from different producing areas and markets. In addition, 35 batches of Bombyx Batryticatus from 2019 to 2022 were used to verify the silk gland after revision. Moreover, Beauveria Bassiana was inoculated in the silkworm of 4-5 instars, and standardized rearing was carried out until they die. The death rate and the quality of Bombyx Batryticatus were measured to determine the differences in Bombyx Batryticatus of different instars, and explore the rationality of the infection age of Bombyx Batryticatus in Chinese Pharmacopoeia(2020). The results revealed that in the 102 batches of Bombyx Batryticatus, the qualification rate of silk gland was low; the content of total ash far exceeded the standard; the content of beauvericin varied greatly. The qualification rate of the silk gland of the 35 batches of Bombyx Batryticatus was only 47.49%, which could be increased to 73.00% if the number of silk gland was 2 to 4. The death rate of Bombyx Batryticatus at different infection ages was quite different, with uneven quality. Generally, the yield of Bombyx Batryticatus inoculated on the first day of the fifth instar was high with good quality. Therefore, in combination with the quality and actual production of Bombyx Batryticatus, the following suggestions were proposed for revision of Bombyx Batryticatus in Chinese Pharmacopoeia(2025): The number of silk gland should be revised as 2-4 bright brown or bright black silk glands, after which, the quality of Bombyx Batryticatus could be guaranteed, and the "quality identification based on character" could also be reflected scientifically; the content determination index that the content of beauvericin shall not be less than 0.017% should be added to better control the quality of Bombyx Batryticatus; the infection age should be revised as the first day of the fifth instar to narrow the age span, which could better fit the actual production and ensure the quality of Bombyx Batryticatus.
